Gregory A. Bonfiglio is the Managing Partner of Proteus Venture Partners - a new venture fund that will focus solely on stem cell & regenerative medicine companies. He is in the process of raising the investment capital for that Fund, and is seeking new stem cell & regenerative medicine investment opportunities. Greg was an early investor in stem cell & regenerative medicine companies - his prior firm, Anthem Venture Partners, funded Advanced Cell Technology (ACTC.OB) in 2000, and Mr. Bonfiglio led the team that took the Company public in early 2005.

Mr. Bonfiglio continues to be an active participant in the field of Regenerative Medicines. He is a frequent speaker at Regenerative Medicine Conferences. He is a Member of the ISSCR and is on their Industry Committee. He also is a Member of the ISCT and is on their Commercialization Committee. Mr. Bonfiglio is on the Board of VistaGen Therapeutics.

From 2000 - 2005, Greg was a General Partner with Anthem Venture Partners - a diversified early stage venture fund in California, with returns in the Top 5% of all 2000 funds. Prior to joining Anthem, he was a Partner with Morrison & Foerster, where he worked extensively with technology clients. From 1996 to 2000, Mr. Bonfiglio was an Adjunct Professor of Law at Stanford Law School. Since 1995, he has been a regular Guest Lecturer at the UC Berkley Haas Business School.